These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34254691)

  • 21. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
    Gronchi A; Miceli R; Allard MA; Callegaro D; Le Péchoux C; Fiore M; Honoré C; Sanfilippo R; Coppola S; Stacchiotti S; Terrier P; Casali PG; Le Cesne A; Mariani L; Colombo C; Bonvalot S
    Ann Surg Oncol; 2015 May; 22(5):1447-54. PubMed ID: 25300609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Méeus P; Stoeckle E; Riou O; Isambert N; Bompas E; Jafari M; Delcambre-Lair C; Saada E; Le Cesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):735-742. PubMed ID: 24567518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
    Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
    J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort study.
    Zheng J; Zhuang A; Xia X; Miao F; Wang Z; Kong X; Ren Y; Ma Y; Lin Z; Lu W; Li W
    Discov Oncol; 2023 Nov; 14(1):197. PubMed ID: 37910291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
    Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
    World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center.
    Xue G; Wang Z; Li C; Lv A; Tian X; Wu J; Qiu H; Hao C
    Int J Clin Oncol; 2021 Jan; 26(1):145-153. PubMed ID: 33068222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factor Analysis and Nomogram Construction of Primary Retroperitoneal Liposarcoma: A Review of 10 Years of Treatment Experience in a Single Asian Cohort of 211 Cases.
    Zhuang A; Zhuang A; Wu Q; Lu W; Tong H; Zhang Y
    Front Oncol; 2021; 11():777647. PubMed ID: 35096578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
    Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
    Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study.
    Sourrouille I; Macovei R; Faron M; Le Péchoux C; Mir O; Adam J; Dumont S; Terrier P; Le Cesne A; Honoré C
    Ann Surg Oncol; 2018 Aug; 25(8):2201-2208. PubMed ID: 29797115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival nomograms for patients with retroperitoneal soft tissue sarcoma based on the SEER database and an external cohort.
    Wu J; Zhang Y; Yao G; Tuersunmaimaiti A; Azhati Y; Mamuti A; Wen H; Tuxun T
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15013-15026. PubMed ID: 37610674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.
    Malinka T; Nebrig M; Klein F; Pratschke J; Bahra M; Andreou A
    BMC Surg; 2019 Jun; 19(1):61. PubMed ID: 31182086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
    Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
    Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma.
    Willis F; Musa J; Schimmack S; Hinz U; Mechtersheimer G; Uhl M; Schmidt T; Fröhling S; Büchler MW; Schneider M
    Eur J Surg Oncol; 2021 Aug; 47(8):2189-2200. PubMed ID: 33980415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
    Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
    J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.